Handugan, Rosalina A.

HRN: 11-32-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2022
AZITHROMYCIN 500MG TABLET (TAB)
09/13/2022
09/17/2022
PO
500 Mg
Od
CAP-MR
Waiting Final Action 

Indication:  EmpiricEmpirical De-escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: